TScan Therapeutics
tscan.com · 162 people
- Open roles
- 7
- Remote
- 0
- Headcount
- 162
- Offices
- 1
About TScan Therapeutics
TScan is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system. TScan Therapeutics is a fully integrated, next-generation TCR-T cell therapy company. Founded in 2018, TScan’s platform was developed by Stephen Elledge, Ph.D., and Tomasz Kula, Ph.D., at Brigham and Women’s Hospital and Harvard Medical School. TScan’s transformative platform enables rapid discovery of TCRs and targets for engineered T cell therapy. This technology is extremely versatile and is applicable across multiple therapeutic areas beyond cancers, including autoimmune disorders and infectious diseases.
Markets
Offices
Backed by
Open roles at TScan Therapeutics
- 2 days ago
- Last week
- 4 weeks ago
- 6 weeks ago
- 7 weeks ago
- 3 months ago
- 3 months ago
Apply on autopilot
Tell me once what you are looking for. Every morning I rank the whole catalog against your profile, pick the openings worth your time, and prepare a tailored resume and cover letter for each one.
Applications finish as drafts. Nothing is sent until you read it and press send. New accounts start with 500 free credits.
Counted from the job board TScan Therapeutics publishes. Refolk is not affiliated with TScan Therapeutics and does not handle their hiring.